摘要
Fecal microbiota transplantation(FMT)has emerged as an effective treatment for recurrent Clostridioides difficile infection(CDI)and is recommended as a standard of care(1).Since the first randomized clinical trial published in 2013,there has been an exponential rise in the number of FMTs being performed(2).However,access to FMT varies according to location and type of healthcare establishment and is complicated by the regulatory issues surrounding its use(3,4).Storing and banking stool may be an accessible and economical option for patients requiring FMT,considering the costs associated with donor screening,stool processing and storage by individual providers(5).
